ONEOK heads into its Q1 2026 results with a notably constructive analyst backdrop — but the stock has spent much of the past month giving ground, leaving the earnings print as the first real test of that optimism.
The analyst community shifted meaningfully more bullish in the weeks leading up to this report. Morgan Stanley lifted its target to $113 on April 7 — the highest on the Street — while maintaining Overweight. Jefferies raised its target to $100 and upgraded the stock in late March, then nudged it higher again in early April. Wells Fargo upgraded from Equal-Weight to Overweight on March 25, taking its target to $100. The direction of travel is clear: the Street is broadly positive, with the consensus mean price target at $93.43 against a close of $89.79, implying modest upside. Bulls focus on accelerating system volumes and the company's investment-grade balance sheet, which provides financial flexibility in a choppy macro environment. Bears counter with concerns about prolonged softness in U.S. natural gas volumes and weaker ethane recoveries, which have already nudged some estimates modestly lower.
Short interest is not the dominant story here, but it adds a little texture. At 4.2% of the free float, it has eased roughly 10% over the past month — shorts have been trimming, not adding, through March and April. Borrowing costs remain low at 0.44% and have fallen about 14% over the past week, confirming there is no squeeze dynamic in play. The borrow market is relaxed going into the print, with availability well within normal ranges. Options positioning has edged slightly more defensive than usual — the put/call ratio is running at 0.38, above its 20-day average of 0.33 and around 1.3 standard deviations elevated — but far from a stressed reading. The 52-week high on PCR is 0.85; today's level is closer to the floor than the ceiling.
The past two earnings reactions for ONEOK offer a mixed picture. After the February 2026 print, the stock fell roughly 5-6% on the day and continued lower over the following week. The Q3 print, by contrast, produced a 2.5% gain on the day and extended to 3.5% over five days. The Q1 2026 result will test whether accelerating volume growth and cash flow generation have built enough momentum to validate a target range that, at its high end, sits more than 25% above the current price.
See the live data behind this article on ORTEX.
Open OKE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.